February 2021
Letter to Congressional Leadership, February 3, 2021
January 2021
Letter to President-Elect Biden and Vice President-elect Harris
Letter to President Biden on the Acting FDC Commissioner
December 2020
Sign-on Letter to Leader McConnell and Speaker Pelosi
October 2020
Letter to House Select Subcommittee on the Coronavirus Crisis, October 29, 2020
Letter to Speaker Pelosi and Secretary Mnuchin, October 19, 2020
Letter on Supplemental Spending, October 1, 2020
September 2020
Letter to Congressional Leadership, September 17, 2020
August 2020
Letter to Congressional Leadership, August 20, 2020
Letter to Congressional Leadership, August 5, 2020
July 2020
Letter to HELP Committee, July 20, 2020
Letter to Congressional Leadership, July 16, 2020
Letter to President Trump, July 15, 2020
Letter to "Labor-H" Appropriations Subcommittee, July 2, 2020
June 2020
Letter to Representatives Degette and Upton in Support of Cures 2.0, June 18, 2020
Letter to Congressional Leadership, June 16, 2020
May 2020
Testimony of Research!America to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Concerning Fiscal Year 2021 Appropriations for NIH, CDC, and AHRQ Submitted for the Record, May 20, 2020
Comments on Supplemental Notice of Proposed Rulemaking to the Rule “Strengthening Transparency in Regulatory Science”
Letter to Secretary Azar Regarding EcoHealth Alliance Grant, May 12, 2020
Testimony of Research!America to the Senate Committee on Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies Concerning FY21 Appropriations for NSF, May 4, 2020
April 2020
Letter to Congressional Leadership, April 30, 2020
Multisociety Letter Regarding Discrimination Against People of Asian Descent
Letter to Appropriations Leadership
Testimony of Research!America to the Senate Committee on Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Concerning Fiscal Year 2021 Appropriations for FDA
March 2020
Testimony of Research!America to the House Committee on Appropriations Subcommittee on Commerce, Justice, Science, and Related Agencies Concerning FY21 Appropriations for NSF
December 2019
Letter to Leadership on Completing FY20 Appropriations Process
October 2019
Letter to Congressional Leadership on Continuing Resolutions
September 2019
Letter on FY20 Appropriations
July 2019
Letter of Support for H.R. 3877, Bipartisan Budget Act
Letter of Support for H.R. 3038, Securing American Science and Technology Act of 2019
Letter to White House and Congressional Leadership Urging Action on a Budget Deal
June 2019
Letter of Support for Pocan Amendment
May 2019
Letter from Coalitions representing 500 combined member organizations regarding budget caps
Letter to House and Senate Leadership regarding Budget Caps
Letter to Homeland Security and Government Affairs Committee regarding FACA
April 2019
Testimony of Research!America to the Senate Committee on Appropriations Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Concerning Fiscal Year 2020 Appropriations for FDA
March 2019
Testimony of Research!America to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies
Letter to Senate Leadership in response to Request for Information on ways to reduce healthcare spending
February 2019
Open Letter to Congress and the President of the United States on Harm to American Science from Shutdown
January 2019
Letter to Senate Leadership in acknowledgement of confirmation of OSTP Director Dr. Kelvin Droegemeier
November 2018
Letter to House and Senate Leadership on Completing FY19 Appropriations
October 2018
Research Community Thank You Letter to Labor-HHS Leadership on FY19 Conference Report
July 2018
Letter to Senate Labor-HHS Subcommittee Leadership on FY19 appropriations request for NIH, CDC and AHRQ
June 2018
Letter to Senate and House Leadership from Research!America and the Network for Excellence in Health Innovation (NEHI) regarding the proposed rescissions package
May 2018
Letter from Research!America on 302(b) Allocations
Letter to Senate and House Leadership regarding rescissions package
Letter to Senate Finance Committee and House Ways and Means Committee Leadership regarding rescissions package
Letter to Senate and House Appropriation Committee Leadership regarding 302(b) allocations
April 2018
Letter to Senate and House Labor-H Committee Leadership regarding FY18 appropriations
February 2018
Joint Letter from Research Leaders to Senate and House Leadership regarding 302(b) allocations
Letter to Senate and House Leadership and Appropriations Committee Leadership regarding FY18 appropriations request
January 2018
Letter to Senate and House Leadership regarding the opioid crisis
Letter to Senate and House Appropriations Committee Leadership regarding FY18 appropriations request
November 2017
Letter to Senate and House Leaders regarding FY18 budget
September 2017
Letter to Senate Leadership on Prevention and Public Health Fund
July 2017
Letter to Senate and House Leaders regarding FY18 sequestration
March 2017
Letter to Members of the Senate and House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies on FY17 Appropriations
Letter to Members of the Senate and House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on FY18 Appropriations
Letter to Members of the Senate and House Subcommittee on Commerce, Justice, Science, and Related Agencies on FY18 Appropriations
Testimony to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Concerning Fiscal Year 2018 Appropriations for NIH, CDC, and AHRQ
February 2017
Letter to Members of Congress regarding Research!America's FY18 Appropriations Request
January 2017
Letter to Senate and House leaders on FY17 and FY18 appropriations
November 2016
Letter to Paul Ryan on continuing resolution for FY17
Letter to Senate and House leaders on 21st Century Cures legislation
Letter to Senate and House leaders on FY17 appropriations bills
October 2016
Letter to Senate and House leaders on 21st Century Cures legislation
July 2016
Letter to the Senate and House leaders on Zika funding
May 2016
Letter to Republican National Committee Chairman Reince Priebus to include investments in public health in the Republican Party Platform
Letter to Democratic National Committee Chairwoman, The Honorable Deborah Wasserman Schultz to include investments in public health in the Democratic Party Platform
April 2016
Letter to the Senate Committee on Health, Education, Labor and Pensions on Innovations legislation
Letter to the Senate Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on FY17 appropriations for NIH, CDC, and AHRQ
Letter to the House Subcommittee on Labor, Health and Human Services, Education, and Related Agencies on FY17 appropriations for NIH, CDC, and AHRQ
February 2016
Letter to the House Subcommittee on Commerce, Justice, Science, and Related Agencies to increase funding for the NSF in the FY17 budget
Letter to the House Subcommittee on Agriculture, Rural Development, Food and Drug Administration, and Related Agencies to increase funding for the FDA in the FY17 budget
Letter to the Senate Committee on Labor, Health and Human Services, Education, and Related Agencies to increase funding for NIH, CDC and NIH in the FY17 budget
Letter to the House Committee on Labor, Health and Human Services, Education, and Related Agencies to increase funding for NIH, CDC and NIH in the FY17 budget
November 2015
Letter to the House Committee on Ways and Means and Senate Committee on Finance to repeal the medical device tax
Letter to the House and Senate Labor, Health and Human Services, Education and Related Agencies Appropriations Subcommittee leadership to increase funding for the NIH, CDC and AHRQ in the FY16 budget
Letter to the House and Senate Commerce, Justice and Science Appropriations Subcommittee leadership to increase funding for the NSF in the FY16 budget
Letter to the House and Senate Agriculture Appropriations Subcommittee leadership to increase funding for the FDA in the FY16 budget
October 2015
Joint Statement by the Aerospace Industries Association, the National Defense Industrial Association, Research!America and United for Medical Research urging Congress to lift discretionary spending caps
Letter to the Committee on Health, Education, Labor and Pensions leadership on Innovations for Healthier Americans
May 2015
Letter to the Committee on Energy & Commerce commenting on the NIH Innovation Fund
April 2015
Letter to the Conference Committee for the Fiscal Year 2016 budget resolution
Testimony of Research!America to the Senate Committee on Finance Subcommittee on Health Care
Letter to the Committee on Science, Space and Technology commenting on the America COMPETES Reauthorization Act of 2015 (H.R. 1806)
Letter to the Committee on Appropriations commenting on increased funding for NIH, CDC and AHRQ as part of Appropriations 302(b)
Testimony of Research!America to the House Committee on Appropriations Subcommittee on
Labor, Health and Human Services, Education, and Related Agencies
Testimony of Research!America to the House Committee on Appropriations Subcommittee on
Commerce, Justice, Science, and Related Agencies Concerning FY16 Appropriations for NSF
March 2015
Letter to Members of Congress regarding Research!America's FY16 Appropriations Request
Testimony to the House Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies for the Budget Hearing on the National Institutes of Health
February 2015
Statement for the record of the House Committee on Ways and Means' markup of H.R. 880, a bill to amend the Internal Revenue Code of 1986 to simplify and make permanent the research credit.
November 2014
Letter to congressional leaders urging them to pass an omnibus appropriations bill that boosts funding for NIH, CDC, FDA, AHRQ and NSF
Testimony Before the Senate Appropriations Committee Hearing titled "U.S. Government Response: Fighting Ebola and Protecting America"
May 2014
Testimony to the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies Concerning FY15 Appropriations for the NIH, CDC and AHRQ
February 2014
Letter to appropriators thanking them for the funding increase provided to the FDA in the Consolidated Appropriations Act of 2014
January 2014
Letter to the President urging him to champion medical and health research in the FY15 budget
